Given the role of MUC17 mutations in chemoresistance and in early onset breast cancer (33, 34), its high prevalence and exclusive occurrence in the Kenyan samples that are prone to early onset of breast cancer should be investigated further. This evidence concerns the gene MUC17 and breast cancer.